Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad103 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Enrique Soto-Pedre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Health & Genomics, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Osteoporosis, Diabetes Mellitus, Cerebrovascular Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHS Tayside Research Endowments.
Abstract (Originalsprache)
Context
Primary hyperparathyroidism (PHPT) is associated with increased risk of morbidity and death, and vitamin D levels are a potentially confounding variable.
Objective
The aim of this study was to assess morbidity and mortality associated with primary hyperparathyroidism (PHPT).
Methods
In this population-based retrospective matched cohort study, data linkage of biochemistry, hospital admissions, prescribing, imaging, pathology, and deaths was used to identify patients across the region of Tayside, Scotland, who had PHPT from 1997 to 2019. Cox proportional hazards models and hazards ratios (HR) were used to explore the relationship between exposure to PHPT and several clinical outcomes. Comparisons were made with an age- and gender-matched cohort.
Results
In 11 616 people with PHPT (66.8% female), with a mean follow-up period of 8.8 years, there was an adjusted HR of death of 2.05 (95% CI, 1.97-2.13) for those exposed to PHPT. There was also an increased risk of cardiovascular disease (HR = 1.34; 95% CI, 1.24-1.45), cerebrovascular disease (HR = 1.29; 95% CI, 1.15-1.45), diabetes (HR = 1.39; 95% CI, 1.26-1.54), renal stones (HR = 3.02; 95% CI, 2.19-4.17) and osteoporosis (HR = 1.31; 95% CI, 1.16-1.49). Following adjustment for serum vitamin D concentrations (n = 2748), increased risks for death, diabetes, renal stones, and osteoporosis persisted, but not for cardiovascular or cerebrovascular disease.
Conclusion
In a large population-based study, PHPT was associated with death, diabetes, renal stones, and osteoporosis, independent of serum vitamin D concentration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Population Health & Genomics, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.
- Department of Endocrinology and Diabetes, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.
- School of Medicine, University of Bristol, Bristol BS8 1QU, UK.
- Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.
ORCID-Profile: Enrique Soto-Pedre
Förderung
- NHS Tayside Research Endowments
Zitieren
APA
Soto-Pedre, E., Lin, Y. Y., Soto-Hernaez, J., Newey, P. J., & Leese, G. P. (2023). Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad103
Vancouver
Soto-Pedre E, Lin YY, Soto-Hernaez J, Newey PJ, Leese GP. Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad103
BibTeX
@article{SotoPedre2023,
author = {Soto-Pedre, Enrique and Lin, Yeun Yi and Soto-Hernaez, Jimena and Newey, Paul J and Leese, Graham P},
title = {Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad103}
}
EUVIMED